Suppr超能文献

全外显子组测序流程中三种DNA样本追踪工具的性能评估

Performance Evaluation of Three DNA Sample Tracking Tools in a Whole Exome Sequencing Workflow.

作者信息

Wils Gertjan, Helsmoortel Céline, Volders Pieter-Jan, Vereecke Inge, Milazzo Mauro, Vandesompele Jo, Coppieters Frauke, De Leeneer Kim, Lefever Steve

机构信息

pxlence BVBA, Dendermonde, Belgium.

Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium.

出版信息

Mol Diagn Ther. 2022 Jul;26(4):411-419. doi: 10.1007/s40291-022-00585-3. Epub 2022 May 28.

Abstract

INTRODUCTION

Next-generation sequencing applications are becoming indispensable for clinical diagnostics. These experiments require numerous wet- and dry-laboratory steps, each one increasing the probability of a sample swap or contamination. Therefore, identity confirmation at the end of the process is recommended to ensure the right data are used for each patient.

METHODS

We tested three commercially available, single nucleotide polymorphism (SNP)-based sample tracking kits in a diagnostic workflow to evaluate their ease of use and performance. The coverage uniformity, on-target specificity, sample identification, and genotyping performance were determined to assess the reliability and cost effectiveness of each kit.

RESULTS AND DISCUSSION

Hands-on time and manual steps are almost identical for the kits from pxlence and Nimagen. The Swift kit has an extra purification step, making it the longest and most demanding protocol. Furthermore, the Swift kit failed to correctly genotype 26 of the 46 samples. The Nimagen kit identified all but one sample and the pxlence kit unambiguously identified all samples, making it the most reliable and robust kit of this evaluation. The Nimagen kit showed poor on-target mapping rates, resulting in deeper sequencing needs and higher sequencing costs compared with the other two kits.

CONCLUSION

Our conclusion is that the Human Sample ID kit from pxlence is the most cost effective of the three tested tools for DNA sample tracking and identification.

摘要

引言

下一代测序应用在临床诊断中变得不可或缺。这些实验需要众多湿实验室和干实验室步骤,每一步都会增加样本交换或污染的可能性。因此,建议在流程结束时进行身份确认,以确保为每位患者使用正确的数据。

方法

我们在诊断工作流程中测试了三种市售的基于单核苷酸多态性(SNP)的样本追踪试剂盒,以评估其易用性和性能。通过测定覆盖均匀性、靶向特异性、样本识别和基因分型性能来评估每个试剂盒的可靠性和成本效益。

结果与讨论

pxlence和Nimagen试剂盒的实际操作时间和手动步骤几乎相同。Swift试剂盒有一个额外的纯化步骤,使其成为最长且要求最高的方案。此外,Swift试剂盒在46个样本中有26个未能正确进行基因分型。Nimagen试剂盒除一个样本外识别出了所有样本,而pxlence试剂盒明确识别出了所有样本,使其成为本次评估中最可靠、最稳健的试剂盒。Nimagen试剂盒的靶向映射率较低,与其他两个试剂盒相比,导致测序需求更深且测序成本更高。

结论

我们的结论是,pxlence的人类样本识别试剂盒是三种测试工具中用于DNA样本追踪和识别最具成本效益的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验